Genpact (G) Competitors

$32.10 +0.43 (+1.35%)

Closing price 03:59 PM Eastern

Extended Trading

$32.01 -0.09 (-0.28%)

As of 07:16 PM Eastern

G vs. CCRN, EXLS, GPN, BR, and JKHY

Should you buy Genpact stock or one of its competitors? MarketBeat compares Genpact with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Genpact include Cross Country Healthcare (CCRN), ExlService (EXLS), Global Payments (GPN), Broadridge Financial Solutions (BR), and Jack Henry & Associates (JKHY).

How does Genpact compare to Cross Country Healthcare?

Genpact (NYSE:G) and Cross Country Healthcare (NASDAQ:CCRN) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Genpact has a net margin of 11.04% compared to Cross Country Healthcare's net margin of -9.84%. Genpact's return on equity of 22.70% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Genpact has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market.

Genpact currently has a consensus price target of $43.29, suggesting a potential upside of 34.85%. Cross Country Healthcare has a consensus price target of $12.72, suggesting a potential downside of 2.97%. Given Genpact's stronger consensus rating and higher probable upside, analysts plainly believe Genpact is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Genpact has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.07	$552.49M	$3.26	9.85
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

In the previous week, Genpact had 5 more articles in the media than Cross Country Healthcare. MarketBeat recorded 7 mentions for Genpact and 2 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 1.05 beat Genpact's score of 0.21 indicating that Cross Country Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cross Country Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.0% of Genpact shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 1.6% of Genpact shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Genpact beats Cross Country Healthcare on 13 of the 15 factors compared between the two stocks.

How does Genpact compare to ExlService?

ExlService (NASDAQ:EXLS) and Genpact (NYSE:G) are both mid-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

92.9% of ExlService shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 4.0% of ExlService shares are held by company insiders. Comparatively, 1.6% of Genpact shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, ExlService and ExlService both had 7 articles in the media. ExlService's average media sentiment score of 0.80 beat Genpact's score of 0.21 indicating that ExlService is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ExlService	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Genpact	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

ExlService presently has a consensus target price of $41.50, suggesting a potential upside of 41.01%. Genpact has a consensus target price of $43.29, suggesting a potential upside of 34.85%. Given ExlService's stronger consensus rating and higher possible upside, equities research analysts clearly believe ExlService is more favorable than Genpact.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ExlService	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
Genpact	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13

ExlService has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Genpact has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Genpact has higher revenue and earnings than ExlService. Genpact is trading at a lower price-to-earnings ratio than ExlService, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ExlService	$2.09B	2.15	$251.02M	$1.57	18.75
Genpact	$5.08B	1.07	$552.49M	$3.26	9.85

ExlService has a net margin of 11.66% compared to Genpact's net margin of 11.04%. ExlService's return on equity of 28.50% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ExlService	11.66%	28.50%	15.48%
Genpact	11.04%	22.70%	10.42%

Summary

ExlService beats Genpact on 11 of the 15 factors compared between the two stocks.

How does Genpact compare to Global Payments?

Genpact (NYSE:G) and Global Payments (NYSE:GPN) are both data processing & outsourced services companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

96.0% of Genpact shares are owned by institutional investors. Comparatively, 89.8% of Global Payments shares are owned by institutional investors. 1.6% of Genpact shares are owned by company insiders. Comparatively, 0.6% of Global Payments shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Genpact presently has a consensus price target of $43.29, suggesting a potential upside of 34.85%. Global Payments has a consensus price target of $84.29, suggesting a potential upside of 19.08%. Given Genpact's stronger consensus rating and higher possible upside, analysts plainly believe Genpact is more favorable than Global Payments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13
Global Payments	3 Sell rating(s)	16 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.04

Genpact has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Global Payments has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

In the previous week, Global Payments had 1 more articles in the media than Genpact. MarketBeat recorded 8 mentions for Global Payments and 7 mentions for Genpact. Global Payments' average media sentiment score of 0.23 beat Genpact's score of 0.21 indicating that Global Payments is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Global Payments	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.3%. Global Payments pays an annual dividend of $1.00 per share and has a dividend yield of 1.4%. Genpact pays out 23.0% of its earnings in the form of a dividend. Global Payments pays out -49.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genpact has raised its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Global Payments has higher revenue and earnings than Genpact. Global Payments is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.07	$552.49M	$3.26	9.85
Global Payments	$7.71B	2.51	$1.40B	-$2.04	N/A

Genpact has a net margin of 11.04% compared to Global Payments' net margin of -7.99%. Genpact's return on equity of 22.70% beat Global Payments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
Global Payments	-7.99%	13.11%	5.79%

Summary

Genpact beats Global Payments on 11 of the 19 factors compared between the two stocks.

How does Genpact compare to Broadridge Financial Solutions?

Broadridge Financial Solutions (NYSE:BR) and Genpact (NYSE:G) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

In the previous week, Broadridge Financial Solutions had 1 more articles in the media than Genpact. MarketBeat recorded 8 mentions for Broadridge Financial Solutions and 7 mentions for Genpact. Broadridge Financial Solutions' average media sentiment score of 0.87 beat Genpact's score of 0.21 indicating that Broadridge Financial Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Broadridge Financial Solutions	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Genpact	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Broadridge Financial Solutions has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Broadridge Financial Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Broadridge Financial Solutions	$6.89B	2.51	$839.50M	$9.34	15.98
Genpact	$5.08B	1.07	$552.49M	$3.26	9.85

Broadridge Financial Solutions presently has a consensus price target of $221.57, indicating a potential upside of 48.50%. Genpact has a consensus price target of $43.29, indicating a potential upside of 34.85%. Given Broadridge Financial Solutions' stronger consensus rating and higher probable upside, analysts plainly believe Broadridge Financial Solutions is more favorable than Genpact.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Broadridge Financial Solutions	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Genpact	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13

Broadridge Financial Solutions pays an annual dividend of $3.90 per share and has a dividend yield of 2.6%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.3%. Broadridge Financial Solutions pays out 41.8% of its earnings in the form of a dividend. Genpact pays out 23.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Broadridge Financial Solutions has raised its dividend for 18 consecutive years and Genpact has raised its dividend for 6 consecutive years. Broadridge Financial Solutions is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Broadridge Financial Solutions has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Genpact has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

Broadridge Financial Solutions has a net margin of 15.03% compared to Genpact's net margin of 11.04%. Broadridge Financial Solutions' return on equity of 40.14% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Broadridge Financial Solutions	15.03%	40.14%	12.87%
Genpact	11.04%	22.70%	10.42%

90.0% of Broadridge Financial Solutions shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 1.1% of Broadridge Financial Solutions shares are owned by company insiders. Comparatively, 1.6% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Broadridge Financial Solutions beats Genpact on 16 of the 19 factors compared between the two stocks.

How does Genpact compare to Jack Henry & Associates?

Genpact (NYSE:G) and Jack Henry & Associates (NASDAQ:JKHY) are both mid-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Jack Henry & Associates has a net margin of 20.64% compared to Genpact's net margin of 11.04%. Jack Henry & Associates' return on equity of 24.03% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
Jack Henry & Associates	20.64%	24.03%	17.02%

Genpact currently has a consensus target price of $43.29, indicating a potential upside of 34.85%. Jack Henry & Associates has a consensus target price of $192.08, indicating a potential upside of 37.37%. Given Jack Henry & Associates' stronger consensus rating and higher possible upside, analysts plainly believe Jack Henry & Associates is more favorable than Genpact.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13
Jack Henry & Associates	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.79

Genpact has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Jack Henry & Associates has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

96.0% of Genpact shares are owned by institutional investors. Comparatively, 98.8% of Jack Henry & Associates shares are owned by institutional investors. 1.6% of Genpact shares are owned by company insiders. Comparatively, 0.6% of Jack Henry & Associates shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.3%. Jack Henry & Associates pays an annual dividend of $2.44 per share and has a dividend yield of 1.7%. Genpact pays out 23.0% of its earnings in the form of a dividend. Jack Henry & Associates pays out 34.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genpact has raised its dividend for 6 consecutive years and Jack Henry & Associates has raised its dividend for 35 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Jack Henry & Associates had 3 more articles in the media than Genpact. MarketBeat recorded 10 mentions for Jack Henry & Associates and 7 mentions for Genpact. Jack Henry & Associates' average media sentiment score of 1.17 beat Genpact's score of 0.21 indicating that Jack Henry & Associates is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jack Henry & Associates	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Genpact has higher revenue and earnings than Jack Henry & Associates. Genpact is trading at a lower price-to-earnings ratio than Jack Henry & Associates, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.07	$552.49M	$3.26	9.85
Jack Henry & Associates	$2.38B	4.18	$455.75M	$7.15	19.56

Summary

Jack Henry & Associates beats Genpact on 15 of the 20 factors compared between the two stocks.

Get Genpact News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

G vs. The Competition

Export

Metric	Genpact	IT Services Industry	Computer Sector	NYSE Exchange
Market Cap	$5.37B	$12.93B	$38.68B	$22.89B
Dividend Yield	2.37%	2.47%	3.21%	4.12%
P/E Ratio	9.60	48.94	77.70	30.07
Price / Sales	1.07	6.63	619.12	133.39
Price / Cash	8.34	24.54	46.83	24.68
Price / Book	2.20	3.53	10.16	4.68
Net Income	$552.49M	$537.84M	$1.06B	$1.07B
7 Day Performance	8.91%	2.79%	0.20%	-0.04%
1 Month Performance	-12.29%	-6.59%	3.88%	-1.12%
1 Year Performance	-27.75%	-13.83%	160.75%	22.78%

Genpact Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
G Genpact	4.759 of 5 stars	$32.10 +1.4%	$43.29 +34.9%	-28.2%	$5.37B	$5.08B	9.60	146,500
CCRN Cross Country Healthcare	2.5951 of 5 stars	$13.10 -0.2%	$12.72 -2.9%	-6.0%	$424.53M	$1.05B	N/A	6,784	High Trading Volume
EXLS ExlService	4.4001 of 5 stars	$29.00 +5.5%	$41.50 +43.1%	-37.4%	$4.20B	$2.09B	18.47	65,000
GPN Global Payments	4.192 of 5 stars	$68.69 +1.6%	$84.52 +23.1%	-16.0%	$18.49B	$7.71B	N/A	26,000	Analyst Forecast
BR Broadridge Financial Solutions	4.9824 of 5 stars	$150.67 +3.5%	$221.57 +47.1%	-38.5%	$16.84B	$6.89B	16.13	15,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:G) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genpact (G) Competitors

G vs. CCRN, EXLS, GPN, BR, and JKHY

How does Genpact compare to Cross Country Healthcare?

Summary

How does Genpact compare to ExlService?

Summary

How does Genpact compare to Global Payments?

Summary

How does Genpact compare to Broadridge Financial Solutions?

Summary

How does Genpact compare to Jack Henry & Associates?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

G vs. The Competition

Genpact Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Genpact (G) Competitors

G vs. CCRN, EXLS, GPN, BR, and JKHY

How does Genpact compare to Cross Country Healthcare?

Is G or CCRN more profitable?

Which has more risk & volatility, G or CCRN?

Do analysts recommend G or CCRN?

Which has preferable earnings and valuation, G or CCRN?

Does the media prefer G or CCRN?

Do insiders & institutionals hold more shares of G or CCRN?

Summary

How does Genpact compare to ExlService?

Do insiders and institutionals hold more shares of EXLS or G?

Does the media favor EXLS or G?

Do analysts prefer EXLS or G?

Which has more risk & volatility, EXLS or G?

Which has better earnings and valuation, EXLS or G?

Is EXLS or G more profitable?

Summary

How does Genpact compare to Global Payments?

Do institutionals & insiders hold more shares of G or GPN?

Do analysts recommend G or GPN?

Which has more volatility & risk, G or GPN?

Does the media prefer G or GPN?

Is G or GPN a better dividend stock?

Which has better valuation & earnings, G or GPN?

Is G or GPN more profitable?

Summary

How does Genpact compare to Broadridge Financial Solutions?

Does the media refer more to BR or G?

Which has preferable earnings & valuation, BR or G?

Do analysts rate BR or G?

Is BR or G a better dividend stock?

Which has more risk & volatility, BR or G?

Is BR or G more profitable?

Do institutionals and insiders believe in BR or G?

Summary

How does Genpact compare to Jack Henry & Associates?

Is G or JKHY more profitable?

Do analysts prefer G or JKHY?

Which has more volatility & risk, G or JKHY?

Do institutionals & insiders hold more shares of G or JKHY?

Is G or JKHY a better dividend stock?

Does the media prefer G or JKHY?

Which has stronger earnings & valuation, G or JKHY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

G vs. The Competition

Genpact Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools